HM

HealthCor Management Portfolio holdings

AUM $109M
This Quarter Return
-2.55%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.3B
AUM Growth
-$137M
Cap. Flow
-$105M
Cap. Flow %
-4.55%
Top 10 Hldgs %
49.1%
Holding
90
New
20
Increased
22
Reduced
16
Closed
17

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
$125M
2
COR icon
Cencora
COR
$75.5M
3
CNC icon
Centene
CNC
$61.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$60M
5
MCK icon
McKesson
MCK
$56.2M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$106M
2
HUM icon
Humana
HUM
$106M
3
DHR icon
Danaher
DHR
$103M
4
CVS icon
CVS Health
CVS
$92.8M
5
TMO icon
Thermo Fisher Scientific
TMO
$92.3M

Sector Composition

1 Healthcare 89.61%
2 Consumer Discretionary 4.54%
3 Real Estate 3.95%
4 Financials 1.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DXCM icon
76
DexCom
DXCM
$31.5B
– –
-203,560
Closed -$21.7M
ELEV
77
DELISTED
Elevation Oncology
ELEV
– –
-100,000
Closed -$1.36M
GLPG icon
78
Galapagos
GLPG
$2.05B
– –
-41,080
Closed -$2.83M
GLUE icon
79
Monte Rosa Therapeutics
GLUE
$298M
– –
-100,000
Closed -$2.27M
HUM icon
80
Humana
HUM
$37.3B
– –
-239,030
Closed -$106M
IRWD icon
81
Ironwood Pharmaceuticals
IRWD
$172M
– –
-522,712
Closed -$6.73M
MREO
82
Mereo BioPharma
MREO
$267M
– –
-149,170
Closed -$473K
NVAX icon
83
Novavax
NVAX
$1.18B
– –
0
– –
REGN icon
84
Regeneron Pharmaceuticals
REGN
$61B
– –
-190,380
Closed -$106M
TMO icon
85
Thermo Fisher Scientific
TMO
$181B
– –
-182,970
Closed -$92.3M
VEEV icon
86
Veeva Systems
VEEV
$43.6B
– –
-136,080
Closed -$42.3M
ARYD
87
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
– –
-1,238,881
Closed -$13.3M
CYT
88
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
– –
-120,000
Closed -$2.57M
EQRX
89
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-500,000
Closed -$5.16M
JNCE
90
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-268,295
Closed -$1.82M
1 2 3
4